Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Greyson International Announces Safety Study Results Of Trilexon System

Greyson International, Inc. announced that it has received results from a safety study on Trilexon, a novel delivery system designed by the company that improves effectiveness of topical applications. The study confirms that Trilexon is safe to use and does not cause irritation to the skin. These results allow Greyson to begin marketing Trilexon.

“We are thrilled to receive excellent results from this safety study showing that Trilexon is safe,” said Greyson International CEO Harvey Tauman. “We are now ready to start marketing through several channels, including appearances on national home shopping networks, direct response television, the Internet, licensing of Trilexon for use in various cosmetic, pharmaceutical and topical applications and more. This is an exciting time for Greyson as we can now introduce new and existing customers to the latest advancement in skincare.”

Trilexon also recently received trademark approval, further confirmation that the company is ready to move forward and begin marketing this delivery system.